SRRM4 and small cell lung carcinoma: There have been reports on the development of antisense nucleic acid drugs targeting SRRM4 for the treatment of small-cell lung cancer [16] and its association with autism spectrum disorder [17], and it has been suggested that silencing of SRRM4 in tumors may favor growth [18].